On this page, you will find different kinds of study results:
• A Lay summary which is a summary of clinical trial results written in an easy-to-understand way.
• A summary of results called synopsis which is written in scientific language. It is prepared for Medicines Agencies and Ethics Committees,
• A scientific publication which presents results for scientists and medical doctors.
213 Results
Protocol Code |
Study Title |
Active substance/Medical device |
Study Phase |
Therapeutic Area |
CL3-95005-007 |
An open-label, randomised, phase III study comparing trifluridine/tipiracil in combination with bevacizumab to trifluridine/tipiracil monotherapy…
|
TIPIRACIL, TRIFLURIDINE, S095005
|
Phase 3
|
Cancers
|
|
CL1-64315-004 |
Phase I/II, international, multicentre, open-label, non-randomised, non-comparative, study evaluating the safety, tolerability and clinical activity…
|
S064315
|
Phase 1-2
|
Cancers
|
|
CL2-95011-001 |
A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren’s Syndrome patients.…
|
S095011
|
Phase 2
|
Immune-Inflammatory Diseases
|
|
CL3-05167-005 |
Efficacy and safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in adult patients with arterial…
|
ATORVASTATIN, PERINDOPRIL, S005167
|
Phase 3
|
Cardiovascular Diseases
|
|
CL1-95014-001 |
A Phase 2 Clinical Study of Pegaspargase in Patients With Newly Diagnosed, Untreated Acute Lymphoblastic…
|
PEGASPARGASE, S095014
|
Phase 2
|
Cancers
|
|
CL1-64315-003 |
A Phase I/II, open label, non-randomized study to evaluate safety, tolerability, pharmacokinetics and clinical activity…
|
S064315
|
Phase 1-2
|
Cancers
|
|
CL3-13001-002 |
Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial…
|
Cardioskin™
|
Phase 3
|
Cardiovascular Diseases
|
|
331501 |
Phase II Randomized Study of BAX2398 in Combination With 5-Fluorouracil and Calcium Levofolinate in Japanese…
|
Liposomal Irinotecan, S095013
|
Phase 2
|
Cancers
|
|
CL1-65487-002 |
Study of a New Intravenous Drug, Called S065487, in Patients With Acute Myeloid Leukemia, Non…
|
S065487
|
Phase 1
|
Cancers
|
|
CL1-64315-002 |
An International Phase Ib Multicentre Study to Characterize the Safety and Tolerability of Intravenously Administered…
|
S064315
|
Phase 1
|
Cancers
|
|
CL3-95008-002 |
Efficacy and safety of bumetanide oral liquid formulation in children aged from 2 to less…
|
BUMETANIDE, S095008
|
Phase 3
|
Neuropsychiatric Diseases
|
|
CL3-95008-001 |
Efficacy and safety of bumetanide oral liquid formulation in children and adolescents aged from 7…
|
BUMETANIDE, S095008
|
Phase 3
|
Neuropsychiatric Diseases
|
|
CL2-201086-002 |
Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with…
|
S201086
|
Phase 2
|
Rheumatology
|
|
Control-2 |
Efficacy of ivabradine in combination with beta-blockers vs up-titration of beta-blockers in daily practice
|
IVABRADINE, S016257
|
Phase 4
|
Cardiovascular Diseases
|
|
CL3-05153-008 |
A clinical study to test the safety and the efficacy of a single-pill combination of…
|
AMLODIPINE, ATORVASTATIN, PERINDOPRIL ARGININE, S005153
|
Phase 3
|
Cardiovascular Diseases
|
|
CL3-05682-109 |
Clinical non-inferiority study between Micronized purified flavonoid fraction 1000 mg, one chewable tablet per day…
|
MICRONISED PURIFIED FLAVONOID FRACTION, S005682
|
Phase 3
|
Cardiovascular Diseases
|
|
CL1-95010-001 |
Safety, Tolerability and Pharmacokinetics of S 95010 After Single Escalating Intravenous Doses in Young Healthy…
|
S095010
|
Phase 1
|
Cardiovascular Diseases
|
|
CL3-95005-006 |
An open-label, randomised, phase III Study cOmparing trifLuridine/tipiracil (S 95005) in combination with bevacizumab to…
|
TIPIRACIL, TRIFLURIDINE, S095005
|
Phase 3
|
Cancers
|
|
CL1-81694-003 |
Phase I/II trial of S 81694 administered intravenously in combination with paclitaxel to evaluate the…
|
S081694
|
Phase 1-2
|
Cancers
|
|
CL1-49076-002 |
Phase I/II study of S49076, a multi-target inhibitor of c-MET, AXL, FGFR in combination with…
|
S049076
|
Phase 1-2
|
Cancers
|
|
CL1-80881-002 |
INES - Phase Ib dose allocation study of oral administration of lucitanib given in combination…
|
LUCITANIB, S080881
|
Phase 1
|
Cancers
|
|
CL1-68587-001 |
A phase 1, open label, non-comparative, monocenter study to evaluate the safety and the ability…
|
UCART19, S068587
|
Phase 1
|
Cancers
|
|
IC4-95005-183-DEU |
Prospective, Multicenter, Open-label Phase IV trial of Trifluridine/Tipiracil to Evaluate the Health-related Quality of Life…
|
TIPIRACIL, TRIFLURIDINE, S095005
|
Phase 4
|
Cancers
|
|
SC3-90049-001 |
Assessment of the acceptability of a sublingual formulation of piribedil (S90049), 10 to 30 mg…
|
PIRIBEDIL, S090049
|
Phase 3
|
Neuropsychiatric Diseases
|
|
SC2-90049-003 |
Effect of 3 doses (20, 40 and 60 mg) of a sublingual formulation of piribedil…
|
PIRIBEDIL, S090049
|
Phase 2
|
Neuropsychiatric Diseases
|
|
Servier clinical trials are mainly registered on
EU Clinical Trials Register
The EU Clinical Trials Register contains information on interventional clinical trials on medicines carried out in Europe, which started after 1 May 2004.
SEE MORE
ClinicalTrials.gov
Clinicaltrials.gov is a registry that contains information on clinical studies of human participants carried out around the world.
SEE MORE
ISRCTN registry
The International Standard Randomized Controlled Trial Number (ISRCTN) registry is a primary clinical trial registry recognised by World Health Organization (WHO) and International Committee of Medical Journal Editor (ICMJE) that accepts all clinical research studies.
SEE MORE